After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. The current market capitalization of Quest Diagnostics, Inc is $19.11B. A total of 0.73 million shares were traded on the day, compared to an average of 920.87K shares.
In the most recent transaction, PREVOZNIK MICHAEL E sold 604 shares of DGX for 170.99 per share on Feb 20 ’25. After the transaction, the SVP & General Counsel now owns 39,845 company shares. In a previous transaction on Feb 19 ’25, Plewman Patrick sold 320 shares at 169.71 per share. DGX shares that SVP for Diagnostic Services owns now total 18,082.
Among the insiders who sold shares, Doherty Catherine T. disposed of 899 shares on Feb 20 ’25 at a per-share price of $170.99. This resulted in the EVP, Regional Businesses holding 70,457 shares of DGX after the transaction. In another insider transaction, Doherty Catherine T. sold 535 shares at $169.71 per share on Feb 19 ’25. Company shares held by the EVP, Regional Businesses now total 71,356.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Quest Diagnostics, Inc pays an annual dividend of $3.00, resulting in a dividend yield of 1.74%, and it has a price to earnings (P/E) ratio of 22.38. DGX’s most recent ex-dividend date was 2.06% when it declared a $0.80 quarterly dividend that was paid in cash on 4/7/2025. Previously, the company paid the dividend on 1/14/2025 with an ex-dividend date of 1.85%. The DGX stock dividend was $0.75 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DGX has a high of $172.64 and a low of $123.30.
As of this writing, DGX has an earnings estimate of $2.21 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $2.35 per share and a lower estimate of $2.15.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $61.06, while its Total Shareholder’s Equity was $6.56B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 4.13.
